chloroquine has been researched along with methylprednisolone in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (48.89) | 18.7374 |
| 1990's | 4 (8.89) | 18.2507 |
| 2000's | 10 (22.22) | 29.6817 |
| 2010's | 6 (13.33) | 24.3611 |
| 2020's | 3 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Czarnecki, N; Tappeiner, G; Wolff, K | 1 |
| Famewo, CE; Garvey, MB; Noble, WH | 1 |
| Gauderer, CA; Gleich, GJ | 1 |
| Peters, TJ; Welman, E | 1 |
| Ferguson, AG; Lesch, M; Taegtmeyer, H | 1 |
| Apostoloff, E; Hiepe, F | 1 |
| Blanda, A; Catinella, M; Cigolotti, AC; Gambaro, P | 1 |
| Kitada, H; Konda, S; Nakaizumi, H; Sawada, M; Shimizu, S; Sugai, S; Tachibana, J; Tsukada, S; Yasuda, Y | 1 |
| Braunsteiner, H; Günther, R; Huber, C; Huber, H; Michlmayr, G | 1 |
| Berry, CZ; Goldberg, LC; Shepard, WL | 1 |
| Chinea, G; Oronsky, AL; Perper, RJ; Sanda, M | 1 |
| Kovacs, K; Steinberg, AD | 1 |
| Ignarro, LJ | 1 |
| Mayr, E | 1 |
| Kitridou, RC; Solomon, SD | 1 |
| Burnham, TK; Fine, G; Lester, RS; Murray, K | 1 |
| Ward, PA | 1 |
| Bajdekov, B; Durmisev, A; Michailov, P; Zvetkova, E | 1 |
| Hintner, H; Klein, G; Scholz, S; Tappeiner, G; Wolff, K | 1 |
| Hofstädter, F; Schwab, W | 1 |
| Eady, RP; Hallam, C; Pritchard, DI; Trigg, S | 1 |
| Hatta, N; Imai, T; Sakai, H; Takata, M; Takehara, K; Tsutsui, K | 1 |
| Can, C; Dinc, A; Erdem, H; Pay, S; Simsek, I | 1 |
| Ağildere, AM; Altinörs, N; Aydin, P; Benli, S; Demirhan, B; Kart, H; Yücel, AE | 1 |
| GREENWALD, ES | 1 |
| SILTZBACH, LE | 1 |
| BECKER, B; FINGERMAN, LH; PODOS, SM | 1 |
| VANBREMEERSCH, F | 1 |
| ber Rahman, S | 1 |
| Altinay, G; Ermantaş, N; Okten, O; Oktun, MT; Soy, M; Tunçbilek, N; Turgut, B | 1 |
| Bruch-Gerharz, D; Haust, M; Homey, B; Meller, S | 1 |
| de Leon Bojorge, B; García-de la Puente, S; Orozco-Loza, IL; Zaltzman-Girshevich, S | 1 |
| Aajal, A; Ait Brik, A; Ammour, O; Benajiba, C; El Boussadani, B; El Hangouch, J; Oussama, B; Oussama, O; Raissuni, Z; Tahiri, N | 1 |
| Alotaibi, NH; Bokharee, N; Khan, YH; Khokhar, A; Mallhi, TH; Rasheed, M | 1 |
| Giarolla, J; Parise-Filho, R; Polli, MC; Vassiliades, SV; Vaz, ES | 1 |
8 review(s) available for chloroquine and methylprednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Selected aspects of therapy of systemic lupus erythematosus].
Topics: Chloroquine; Humans; Immunosorbent Techniques; Immunosuppressive Agents; Immunotherapy; Lupus Erythematosus, Systemic; Methylprednisolone; Plasmapheresis | 1992 |
[Systemic lupus erythematosus and pregnancy. Report of a clinical case].
Topics: Adult; Anti-Inflammatory Agents; Chloroquine; Female; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Pregnancy; Pregnancy Complications; Pregnenediones | 1991 |
[Antirheumatic drugs. 40].
Topics: Aminopyrine; Analgesics; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antimalarials; Antipyrine; Camphor; Chloroquine; Dexamethasone; Esters; Flufenamic Acid; Glucocorticoids; Gold; Humans; Immunosuppressive Agents; Indomethacin; Mefenamic Acid; Methylprednisolone; Nicotinic Acids; Oils, Volatile; Oxyphenbutazone; Prednisolone; Prednisone; Rheumatic Diseases; Salicylates; Triamcinolone | 1969 |
The patient with rheumatoid arthritis.
Topics: Activities of Daily Living; Arthritis, Rheumatoid; Bursitis; Chloroquine; Diagnosis, Differential; Finger Joint; Gold; Gout; Hot Temperature; Humans; Hydroxychloroquine; Methylprednisolone; Neuralgia; Osteoarthritis; Pain; Physical Examination; Physical Exertion; Physical Therapy Modalities; Prednisolone; Rest; Salicylates; Synovectomy; Triamcinolone; Wrist Joint | 1971 |
[COVID-19 pandemia: Impact on the cariovascular system. Data of 1
Topics: Antimalarials; Antiviral Agents; Azithromycin; Betacoronavirus; Cardiomyopathies; Cardiovascular Diseases; Cerebrovascular Disorders; Chloroquine; Comorbidity; Coronary Disease; Coronavirus Infections; COVID-19; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Methylprednisolone; Pandemics; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Virus Internalization | 2020 |
Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials.
Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antimalarials; Antiviral Agents; Chloroquine; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Intensive Care Units; Length of Stay; Lopinavir; Methylprednisolone; Observational Studies as Topic; Patient Admission; Pyrazines; Ritonavir; SARS-CoV-2; Survival Rate | 2021 |
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies.
Topics: Antiviral Agents; Azithromycin; Chloroquine; COVID-19; Dexamethasone; Drug Repositioning; Humans; Hydroxychloroquine; Ivermectin; Methylprednisolone; Pandemics; Reproducibility of Results; SARS-CoV-2 | 2023 |
37 other study(ies) available for chloroquine and methylprednisolone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Lupus erythematosus panniculitis (author's transl)].
Topics: Chloroquine; Complement C3; Cyclophosphamide; Female; Humans; Immunoglobulin M; Lupus Erythematosus, Discoid; Methylprednisolone; Panniculitis, Nodular Nonsuppurative; Skin; Tetracycline | 1979 |
Pulmonary vascular effects of acetylsalicylic acid, chloroquine, dextran and methylprednisolone given after haemorrhagic shock in dogs.
Topics: Animals; Aspirin; Blood Coagulation; Chloroquine; Dextrans; Dogs; Hemodynamics; Lung; Methylprednisolone; Salicylates; Shock, Hemorrhagic; Vascular Resistance | 1977 |
Inhibition of eosinophilotaxis by chloroquine and corticosteroids.
Topics: Adrenal Cortex Hormones; Animals; Chemotaxis, Leukocyte; Chloroquine; Complement C5; Dose-Response Relationship, Drug; Eosinophils; Guinea Pigs; Hydrocortisone; In Vitro Techniques; Methylprednisolone | 1978 |
Prevention of lysosome disruption in anoxic myocardium by chloroquine and methyl prednisolone.
Topics: Aerobiosis; Animals; Chloroquine; Guinea Pigs; Heart; Hypoxia; In Vitro Techniques; Lysosomes; Male; Membranes; Methylprednisolone; Myocardium; Time Factors | 1977 |
Thermoregulation of myocardial protein synthesis.
Topics: Animals; Chloroquine; Extracellular Space; Glucose; Hot Temperature; Hypoxia; In Vitro Techniques; Methylprednisolone; Muscle Proteins; Oxygen; Papillary Muscles; Phenylalanine; Rabbits; Time Factors; Water | 1975 |
DNA autosensitivity in two Japanese sisters.
Topics: Adult; Animals; Autoantibodies; Autoimmune Diseases; Cattle; Chloroquine; Deoxyribonucleases; DNA; Female; Humans; Japan; Methylprednisolone; Skin Tests | 1990 |
[DNA-synthesizing lymphocytes in the blood of patients with disseminated lupus erythematosus, rheumatoid arthritis, and panarteritis nodosa (author's transl)].
Topics: Adult; Aged; Arthritis, Rheumatoid; Azathioprine; Chloroquine; DNA; Female; Gold; Humans; Indomethacin; Leukocyte Count; Lupus Erythematosus, Systemic; Lymphocytes; Male; Methotrexate; Methylprednisolone; Middle Aged; Penicillamine; Polyarteritis Nodosa | 1973 |
Systemic lupus erythematosus complicated by coccidioidomycosis.
Topics: Adrenocorticotropic Hormone; Adult; Amphotericin B; Chloroquine; Coccidioidomycosis; Cortisone; Female; Humans; Lupus Erythematosus, Systemic; Methoxsalen; Methylprednisolone; Prednisolone; Tetracycline | 1968 |
Leukocyte chemotaxis in vivo. II. Analysis of the selective inhibition of neutrophil or mononuclear cell accumulation.
Topics: Animals; Bucladesine; Carrageenan; Chemotaxis; Chloroquine; Chlorpromazine; Chromium Radioisotopes; Clonidine; Colchicine; Cyclophosphamide; Female; Flufenamic Acid; Indomethacin; Inflammation; Leukocyte Transfusion; Leukocytes; Methylprednisolone; Monocytes; Neutrophils; Phenylbutazone; Rats; Transplantation, Homologous; Venoms; Vinblastine | 1974 |
Cyclophosphamide. Drug interactions and bone marrow transplantation.
Topics: Animals; Bone Marrow Transplantation; Chloroquine; Cyclophosphamide; Drug Interactions; Female; Male; Methylprednisolone; Mice; Mice, Inbred Strains; Transplantation Immunology; Transplantation, Homologous | 1972 |
Release of neutral protease and beta-glucuronidase from human neutrophils in the presence of cartilage treated with various immunologic reactants.
Topics: Allopurinol; Arthritis, Rheumatoid; Aspirin; Cartilage; Chloroquine; Colchicine; Factor VIII; Glucuronidase; Hot Temperature; Humans; Immunoglobulin G; Indomethacin; Iodine Radioisotopes; L-Lactate Dehydrogenase; Methylprednisolone; Neutrophils; Peptide Hydrolases; Probenecid; Protein Denaturation; Sulfur Radioisotopes; Synovial Fluid; Triamcinolone Acetonide; Vinblastine | 1974 |
Immunologic concepts of light reactions in lupus erythematosus and polymorphous light eruptions. I. The mechanism of action of hydroxychloroquine.
Topics: Antibodies, Antinuclear; Autoantibodies; Chloroquine; DNA; Erythema; Humans; Hydralazine; Hydroxychloroquine; Injections, Intradermal; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Methotrexate; Methylprednisolone; Prednisone; Protein Binding; Skin Manifestations; Ultraviolet Rays | 1967 |
The chemosuppression of chemotaxis.
Topics: Animals; Chemotaxis; Chloroquine; Guinea Pigs; Hydrocortisone; In Vitro Techniques; Leukocytes; Methylprednisolone; Vitamin A | 1966 |
[Effect of corticosteroids and synthetic antimalarials on he Arthus phenomenon. Histochemical and electron microscopic studies].
Topics: Animals; Arthus Reaction; Capillaries; Chloroquine; Methylprednisolone; Rabbits | 1980 |
[Systemic lupus erythematosus in hereditary complement 4 deficiency].
Topics: Adult; Chloroquine; Complement C4; Drug Therapy, Combination; Female; HLA Antigens; Humans; Immunologic Deficiency Syndromes; Lupus Erythematosus, Systemic; Methylprednisolone; Pedigree | 1984 |
[Pfeifer-Weber-Christian syndrome of the mesentery. Clinical and pathologico-anatomical aspects].
Topics: Adult; Chloroquine; Humans; Lymph Nodes; Male; Mesentery; Methylprednisolone; Panniculitis, Nodular Nonsuppurative; Tomography, X-Ray Computed | 1983 |
Rat eosinophil-mediated antibody-dependent cellular cytotoxicity: investigations of the mechanisms of target cell lysis and inhibition by glucocorticoids.
Topics: Animals; Antibody-Dependent Cell Cytotoxicity; Chloroquine; Colchicine; Cycloheximide; Cytochalasin B; Eosinophils; Female; Methylprednisolone; Rats; Rats, Inbred Strains; Receptors, Fc | 1982 |
Widespread pruritic plaques in a patient with subacute cutaneous lupus erythematosus and hypocomplementemia: response to dapsone therapy.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Complement C3; Complement System Proteins; Cyclosporine; Dapsone; Dermatologic Agents; Female; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Methylprednisolone; Prednisolone; Pruritus; Skin Diseases, Papulosquamous | 1996 |
Sulfasalazine-induced angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Juvenile; Chloroquine; Humans; Immunoblastic Lymphadenopathy; Lymph Nodes; Male; Methotrexate; Methylprednisolone; Sulfasalazine | 2000 |
Pachymeningitis and optic neuritis in rheumatoid arthritis: successful treatment with cyclophosphamide.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meningitis; Methylprednisolone; Middle Aged; Optic Neuritis; Prednisolone | 2001 |
SYSTEMIC LUPUS ERYTHEMATOSUS: TREATMENT WITH ANTIMALARIAL DRUGS.
Topics: Antimalarials; Chloroquine; Dexamethasone; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Methylprednisolone; Prednisone; Triamcinolone | 1964 |
DIFFUSE PULMONARY GRANULOMATOSES AND FIBROSES.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis; Arthritis, Rheumatoid; Beryllium; Chloroquine; Dexamethasone; Eosinophilic Granuloma; Granulomatosis with Polyangiitis; Humans; Lung Diseases; Methylprednisolone; Pharmacology; Pneumoconiosis; Prednisolone; Prednisone; Pulmonary Fibrosis; Radiation Injuries; Sarcoidosis; Scleroderma, Systemic; Silicosis; Therapeutics; Toxicology; Triamcinolone | 1964 |
THE EFFECT OF CORTICOSTEROIDS ON THE RESORPTION OF PARTIAL HYPHEMA IN RABBIT EYES.
Topics: Absorption; Adrenal Cortex Hormones; Aqueous Humor; Betamethasone; Chloroquine; Glucocorticoids; Hemorrhage; Hyphema; Manometry; Methylprednisolone; Ophthalmic Solutions; Pharmacology; Rabbits; Research; Triamcinolone Acetonide | 1965 |
[CUTANEOUS LYMPHOCYTOMAS].
Topics: Chloroquine; Humans; Lymphoma; Methylprednisolone; Neoplasms; Pathology; Pseudolymphoma; Skin Neoplasms | 1965 |
Lupus tumidus: a variant of cutaneous lupus erythematosus.
Topics: Adult; Antirheumatic Agents; Chloroquine; Chronic Disease; Female; Humans; Lupus Erythematosus, Cutaneous; Methylprednisolone; Sunscreening Agents; Treatment Outcome | 2004 |
Nocardiosis in a patient with primary anti-phospholipid syndrome.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Antiphospholipid Syndrome; Antirheumatic Agents; Ceftriaxone; Chloroquine; Female; Humans; Immunocompromised Host; Methylprednisolone; Nocardia Infections; Thrombocytopenia; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
[Light induced subacute cutaneous lupus erythematodes: diagnosis and management].
Topics: Administration, Oral; Administration, Topical; Aged; Anti-Inflammatory Agents; Basement Membrane; Chloroquine; Drug Therapy, Combination; Epithelium; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Methylprednisolone; Photosensitivity Disorders; Skin; Tacrolimus | 2007 |
Prognostic factors in children with membranoproliferative glomerulonephritis type I.
Topics: Adolescent; Alkylating Agents; Child; Child, Preschool; Chloroquine; Complement System Proteins; Cyclophosphamide; Disease Progression; Female; Glomerular Filtration Rate; Glomerulonephritis, Membranoproliferative; Glucocorticoids; Hematuria; Hemoglobins; Humans; Male; Methylprednisolone; Mexico; Nephrotic Syndrome; Renal Insufficiency; Retrospective Studies; Risk Factors; Serum Albumin; Time Factors; Treatment Outcome | 2008 |